Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Randomized, Double-Blind, Placebo-Controlled Pilot Study of the Safety and Efficacy of 10 mg, 30 mg, and 50 mg of Transnasal Ketamine Hydrochloride (PMI-100) for the Treatment of Postoperative Dental Pain


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00488787

Organisation Name: Javelin Pharmaceuticals

Overal Status: Completed

Start Date: March 2001

Last Update: February 7, 2008

Lead Sponsor: Javelin Pharmaceuticals

Brief Summary: Once patients' postoperative pain intensity reaches a moderate-to-severe level, they are randomized to receive intranasal ketamine or placebo. Patients remain in the study unit for 3 hours post administration and assess pain intensity and pain relief throughout the 3 hour postoperative period.

Conditions:
  • Pain, Postoperative


Total execution time in seconds: 0.13853287696838